Company intelligence / Profile preview

Nutrix

Ownership: Private
Employees: ~10
Development stage: Commercial

Overview

Nutrix has developed and commercialized the CortiSense hardware, a non-invasive saliva-based sensor for real-time cortisol measurement, integrated with its gSense digital health platform. The system supports remote patient monitoring, personalized coaching, and chronic disease management. The company has received recognition including the CES Innovation Award 2025 in Digital Health. Clinical results are not directly applicable but early adoption includes support from Mayo Clinic and Swiss innovation agencies.

Therapeutic areas: Metabolic DisordersPsychiatryEndocrinology
Modalities: DeviceDigital health platform
Industry: Physiological Monitoring

Partnerships

Mayo ClinicUniversity of Applied Sciences Northwestern SwitzerlandInnosuisse – Swiss Innovation AgencySimpact FundOIST-Lifetime Ventures

Beyond the preview

Go deeper on Nutrix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nutrix.

Explore the full profile